Small trial, but the slight improvement in the tx arm vs decline in the control arm translated to a p-value of.007. a small molecule glp-1 would probably get through the BBB more efficiently and have better efficacy (or similar efficacy w better tolerability bc can dose it lower systemically)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.